Puri Fortes
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Mammalian therapeutic riboswitches: Engineering and custom ligands.
Journal: Molecular therapy. Nucleic acids
Published: July 24, 2026
Author Correction: Uncovering functional lncRNAs by scRNA-seq with ELATUS.
Journal: Nature communications
Published: January 08, 2025
Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort.
Journal: Science advances
Published: July 10, 2024
Uncovering functional lncRNAs by scRNA-seq with ELATUS.
Journal: Nature communications
Published: February 21, 2024
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.
Journal: Human vaccines & immunotherapeutics
Published: February 12, 2024
Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals.
Journal: ACS nano
Published: November 16, 2023
Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 15, 2023
Editorial: Long non-coding RNAs in viral infections and immunity.
Journal: Frontiers in immunology
Published: April 02, 2023
APLF and long non-coding RNA NIHCOLE promote stable DNA synapsis in non-homologous end joining.
Journal: Cell reports
Published: June 08, 2022
ISR8/IRF1-AS1 Is Relevant for IFNα and NF-κB Responses.
Journal: Frontiers in immunology
Published: December 05, 2021
U1A is a positive regulator of the expression of heterologous and cellular genes involved in cell proliferation and migration.
Journal: Molecular therapy. Nucleic acids
Published: October 20, 2021
Last Updated: 09/26/2026